Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ERNAERNA
1 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ERNEXA THERAPEUTICS INC

CITADEL ADVISORS LLC holds 15,104 shares of ERNA (ERNEXA THERAPEUTICS INC), worth $100,442 as of 2026-Q2. This is a new position.

Current Value

$100,442

Current Shares

15,104

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
15,104
-
$100,4420.0%$6.65
33

Other major holders of ERNA: VANGUARD FIDUCIARY TRUST CO, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc., ASSETMARK, INC, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used